PURPOSE: We developed a method to normalize optical coherence tomography (OCT) signal profiles from two spectral-domain (SD) OCT devices so that the comparability between devices increases. METHODS: We scanned 21 eyes from 14 healthy and 7 glaucoma subjects with two SD-OCT devices on the same day, with equivalent cube scan patterns centered on the fovea (Cirrus HD-OCT and RTVue). Foveola positions were selected manually and used as the center for registration of the corresponding images. A-scan signals were sampled 1.8 mm from the foveola in the temporal, superior, nasal, and inferior quadrants. After oversampling and rescaling RTVue data along the Z-axis to match the corresponding Cirrus data format, speckle noise reduction and amplitude normalization were applied. For comparison between normalized A-scan profiles, mean absolute difference in amplitude in percentage was measured at each sampling point. As a reference, the mean absolute difference between two Cirrus scans on the same eye also was measured. RESULTS: The mean residual of the A-scan profile amplitude was reduced significantly after signal normalization (12.7% vs. 6.2%, P < 0.0001, paired t-test). All four quadrants also showed statistically significant reduction (all P < 0.0001). Mean absolute difference after normalization was smaller than the one between two Cirrus scans. No performance difference was detected between health and glaucomatous eyes. CONCLUSIONS: The reported signal normalization method successfully reduced the A-scan profile differences between two SD-OCT devices. This signal normalization processing may improve the direct comparability of OCT image analysis and measurement on various devices.
PURPOSE: We developed a method to normalize optical coherence tomography (OCT) signal profiles from two spectral-domain (SD) OCT devices so that the comparability between devices increases. METHODS: We scanned 21 eyes from 14 healthy and 7 glaucoma subjects with two SD-OCT devices on the same day, with equivalent cube scan patterns centered on the fovea (Cirrus HD-OCT and RTVue). Foveola positions were selected manually and used as the center for registration of the corresponding images. A-scan signals were sampled 1.8 mm from the foveola in the temporal, superior, nasal, and inferior quadrants. After oversampling and rescaling RTVue data along the Z-axis to match the corresponding Cirrus data format, speckle noise reduction and amplitude normalization were applied. For comparison between normalized A-scan profiles, mean absolute difference in amplitude in percentage was measured at each sampling point. As a reference, the mean absolute difference between two Cirrus scans on the same eye also was measured. RESULTS: The mean residual of the A-scan profile amplitude was reduced significantly after signal normalization (12.7% vs. 6.2%, P < 0.0001, paired t-test). All four quadrants also showed statistically significant reduction (all P < 0.0001). Mean absolute difference after normalization was smaller than the one between two Cirrus scans. No performance difference was detected between health and glaucomatous eyes. CONCLUSIONS: The reported signal normalization method successfully reduced the A-scan profile differences between two SD-OCT devices. This signal normalization processing may improve the direct comparability of OCT image analysis and measurement on various devices.
Authors: Mauro T Leite; Harsha L Rao; Robert N Weinreb; Linda M Zangwill; Christopher Bowd; Pamela A Sample; Ali Tafreshi; Felipe A Medeiros Journal: Am J Ophthalmol Date: 2010-10-20 Impact factor: 5.258
Authors: Michaël J A Girard; Nicholas G Strouthidis; C Ross Ethier; Jean Martial Mari Journal: Invest Ophthalmol Vis Sci Date: 2011-09-29 Impact factor: 4.799
Authors: Michael F Chiang; Michael V Boland; Allen Brewer; K David Epley; Mark B Horton; Michele C Lim; Colin A McCannel; Sayjal J Patel; David E Silverstone; Linda Wedemeyer; Flora Lum Journal: Ophthalmology Date: 2011-06-16 Impact factor: 12.079
Authors: Michelle L Gabriele; Gadi Wollstein; Hiroshi Ishikawa; Larry Kagemann; Juan Xu; Lindsey S Folio; Joel S Schuman Journal: Invest Ophthalmol Vis Sci Date: 2011-04-14 Impact factor: 4.799
Authors: Michelle L Gabriele; Gadi Wollstein; Hiroshi Ishikawa; Juan Xu; Jongsick Kim; Larry Kagemann; Lindsey S Folio; Joel S Schuman Journal: Prog Retin Eye Res Date: 2010-06-11 Impact factor: 21.198
Authors: G Vizzeri; R N Weinreb; A O Gonzalez-Garcia; C Bowd; F A Medeiros; P A Sample; L M Zangwill Journal: Br J Ophthalmol Date: 2009-03-19 Impact factor: 4.638
Authors: Chieh-Li Chen; Hiroshi Ishikawa; Yun Ling; Gadi Wollstein; Richard A Bilonick; Juan Xu; James G Fujimoto; Ian A Sigal; Larry Kagemann; Joel S Schuman Journal: Invest Ophthalmol Vis Sci Date: 2013-11-05 Impact factor: 4.799
Authors: Chieh-Li Chen; Hiroshi Ishikawa; Gadi Wollstein; Richard A Bilonick; Ian A Sigal; Larry Kagemann; Joel S Schuman Journal: Invest Ophthalmol Vis Sci Date: 2015-06 Impact factor: 4.799
Authors: Jean-Claude Mwanza; Hanna Y Kim; Donald L Budenz; Joshua L Warren; Michael Margolis; Scott D Lawrence; Pooja D Jani; Garrett S Thompson; Richard K Lee Journal: Invest Ophthalmol Vis Sci Date: 2015-10 Impact factor: 4.799
Authors: Chieh-Li Chen; Hiroshi Ishikawa; Gadi Wollstein; Richard A Bilonick; Larry Kagemann; Joel S Schuman Journal: Transl Vis Sci Technol Date: 2017-02-28 Impact factor: 3.283
Authors: Chieh-Li Chen; Hiroshi Ishikawa; Gadi Wollstein; Richard A Bilonick; Larry Kagemann; Joel S Schuman Journal: Transl Vis Sci Technol Date: 2016-01-11 Impact factor: 3.283
Authors: Sara Risseeuw; Edwin Bennink; Maarten G Poirot; Pim A de Jong; Wilko Spiering; Saskia M Imhof; Redmer van Leeuwen; Jeannette Ossewaarde-van Norel Journal: Transl Vis Sci Technol Date: 2020-07-23 Impact factor: 3.283